Hotline:
+ 49 (0) 2204 2918806

Market studies for category Healthcare

Items 1 to 10 of 282 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 29
  1. Net price*
    Year
  2. $4,995.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    PharmaPoint: Epilepsy - Germany Drug Forecast and Market Analysis to 2022

    GlobalData
    136 pages
    Introduction GlobalData has released its new Country report, “PharmaPoint: Epilepsy - Germany Drug Forecast and Market Analysis to 2022”. Epilepsy is a brain disorder characterized by spontaneously occurring and recurrent seizures. The market is heavily driven by the sales of antiepileptic drugs (AEDs) targeted at seizure reduction. T
    Englisch | Report | SKU: 330283
  3. $6,995.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Banzel / Inovelon (Epilepsy) - Forecast and Market Analysis to 2022

    GlobalData
    50 pages
    Introduction GlobalData has released its new PharmaPoint Drug Evaluation report, “Banzel / Inovelon (Epilepsy) - Forecast and Market Analysis to 2022”. Epilepsy is a brain disorder characterized by spontaneously occurring and recurrent seizures. The market is heavily driven by the sales of antiepileptic drugs (AEDs) targeted at seizur
    Englisch | Report | SKU: 330447
  4. €1,590.00
    Für diese Studie liegt keine Bewertung vor.

    Dental Practices - Australia

    Global Research & Data Services.
    This register contains information about 2065 dental practices active in Australia. The register includes the following information about the dental practices: •dental practice's name •contact information •financial information •number of employees •contact person The register is in Excel format. Report Highlights
    Englisch | Register | SKU: 78393
  5. €2,900.00
    Für diese Studie liegt keine Bewertung vor.

    Health Care Monitoring 2007

    psychonomics AG & Acxiom Deutschland GmbH
    252 Seiten/ 170 Charts
    Die Studie Health Care Monitoring ist eine umfassende halbjährliche Monitoring-Studie zum deutschen Gesundheitsmarkt (Verbraucherbefragung). Kernthemen: Gesundheitsverhalten; Gesundheitsrelevante Beziehungssysteme; Selbstmedikation & OTC. Zusätzlich wechselnde Highlight-Themen. Differenzierung der Ergebnisse nach Soziodemographia, Krank
    Deutsch | Marktstudie | SKU: 10222
  6. $3,995.00
    2012
    Für diese Studie liegt keine Bewertung vor.

    EpiCast Report: Epilepsy - Epidemiology Forecast to 2022

    GlobalData
    41 pages
    Introduction Epilepsy affects 50 million people worldwide each year and is one of the most common neurological conditions in the world (WHO, 2005). Epilepsy is defined as a collection of brain dysfunction disorders characterized by recurrent and unpredictable seizures. The prevalence of epilepsy varies among countries due to a mosaic of
    Englisch | Report | SKU: 330207
  7. $2,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Atrial Flutter Global Clinical Trials Review, H1, 2013

    GlobalData
    210 pages
    Introduction GlobalData's clinical trial report, “Atrial Flutter Global Clinical Trials Review, H1, 2013" provides data on the Atrial Flutter clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Atrial Flutter. It includes an overview of the trial numbers and their recruitment s
    Englisch | Report | SKU: 330315
  8. €390.00
    Für diese Studie liegt keine Bewertung vor.

    Hospitals - Spain

    Global Research & Data Services.
    This register contains information about 146 hospitals active in Spain. The register includes the following information about the hospitals: - hospital name - contact information - financial information - number of employees - contact person The register is in Excel format. Report Highlights
    Englisch | Register | SKU: 78436
  9. $2,500.00
    2012
    Für diese Studie liegt keine Bewertung vor.

    Head And Neck Cancer Global Clinical Trials Review, H2, 2012

    GlobalData
    149 pages
    Introduction GlobalData's clinical trial report, “Head And Neck Cancer Global Clinical Trials Review, H2, 2012" provides data on the Head And Neck Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Head And Neck Cancer. It includes an overview of the trial numbers and t
    Englisch | Report | SKU: 329568
  10. $2,500.00
    2012
    Für diese Studie liegt keine Bewertung vor.

    Non-Hodgkin Lymphoma Global Clinical Trials Review, H2, 2012

    GlobalData
    160 pages
    Introduction GlobalData's clinical trial report, “Non-Hodgkin Lymphoma Global Clinical Trials Review, H2, 2012" provides data on the Non-Hodgkin Lymphoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Non-Hodgkin Lymphoma. It includes an overview of the trial numbers and t
    Englisch | Report | SKU: 329573
  11. $6,995.00
    2012
    Für diese Studie liegt keine Bewertung vor.

    Zometa (Prostate Cancer) - Forecast and Market Analysis to 2022

    GlobalData
    50 pages
    Introduction GlobalData has released its new PharmaPoint Drug Evaluation report, “Zometa (Prostate Cancer) - Forecast and Market Analysis to 2022”. The recent approvals of second-line metastatic castration-resistant prostate cancer (mCRPC) therapies like J&J’s Zytiga (abiraterone acetate) and Medivation/Astellas’ Xtandi (enzalutam
    Englisch | Report | SKU: 330288

Items 1 to 10 of 282 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 29